
LINK . SPRINGER . COM {
}
Title:
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma | Molecular Cancer
Description:
Background Chimeric antigen receptor (CAR) T-cell therapy using brexucabtagene autoleucel (BA) induces remission in many patients with mantle cell lymphoma (MCL), and BA is the only CAR T-cell therapy approved by the FDA for MCL. However, development of relapses to BA is recognized with poor patient outcomes. Multiple CAR T-cell therapies have been approved for other lymphomas and the resistance mechanisms have been investigated. However, the mechanisms underlying BA relapse in MCL have not been investigated and whether any previously reported resistance mechanisms apply to BA-relapsed patients with MCL is unknown. Methods To interrogate BA resistance mechanisms in MCL, we performed single-cell RNA sequencing on 39 longitudinally collected samples from 15 BA-treated patients, and multiplex cytokine profiling on 80 serial samples from 20 patients. Results We demonstrate that after BA relapse, the proportion of T cells, especially cytotoxic T cells (CTLs), decreased among non-tumor cells, while the proportion of myeloid cells correspondingly increased. TIGIT, LAG3, and CD96 were the predominant checkpoint molecules expressed on exhausted T cells and CTLs; only TIGIT was significantly increased after relapse. CTLs expanded during remission, and then contracted during relapse with upregulated TIGIT expression. Tumor cells also acquired TIGIT expression after relapse, leading to the enhanced interaction of tumor cell TIGIT with monocyte CD155/PVR. In myeloid cells, post-relapse HLA-II expression was reduced relative to pretreatment and during remission. Myeloid-derived suppressor cells (MDSCs) were enriched after relapse with elevated expression of activation markers, including CLU (clusterin) and VCAN (versican). Extracellular chemokines (CCL4, CXCL9, CXCL13), soluble checkpoint inhibitors (sPD-L1, sTIM3, s4-1BB), and soluble receptors (sIL-2R, sTNFRII) were decreased during remission but elevated after relapse. Conclusions Our data demonstrate that multiple tumor-intrinsic and -extrinsic factors are associated with T-cell suppression and BA relapse. Among these, TIGIT appears to be the central player given its elevated expression after BA relapse in not only CTLs but also MCL cells. The acquisition of TIGIT expression on tumor cells is MCL-specific and has not been reported in other CAR T-treated diseases. Together, our data suggest that co-targeting TIGIT may prevent CAR T relapses and thus promote long-term progression-free survival in MCL patients.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Education
- Telecommunications
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We find it hard to spot revenue streams.
While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.
Keywords {🔍}
cells, relapse, fig, cell, expression, pubmed, tigit, tcell, article, mcl, patients, tumor, google, scholar, car, central, supplementary, cancer, myeloid, patient, cytotoxic, ctls, cas, data, remission, lymphoma, therapy, receptor, immune, resistance, samples, increased, soluble, silr, hla, checkpoint, levels, wang, showing, panel, molecules, expressed, study, analysis, mechanisms, collected, significantly, elevated, genes, singlecell,
Topics {✒️}
single-cell t-cell receptor v-set immunoregulatory receptor scrna-seq/tcr library preparation large b-cell lymphoma phorbol 12-myristate 13-acetate/ionomycin inhibiting t-cell expansion article download pdf refractory mantle-cell lymphoma post-relapse hla-ii expression serine/threonine protein kinase car t-cell failure myeloid-derived suppressor cells car t-treated diseases perform single-cell separation sequential single-cell transcriptional mdsc-mediated immune suppression car-t-cell therapy car t-cell therapy car t-cell activity t-cell clone sizes trans-differentiation methylation profile cell-mediated cyeloid activation car t-cell therapies endogenous t-cell suppression car t-cell therapeutics car t-cell resistance building single-cell trajectory car t-cell exhaustion cytotoxic/exhaustion/naïve scoring algorithm regulating t-cell function cd8+ t-cell subpopulations andrew futreal & linghua wang car t-cell relapse exhausted t-cell clones myeloid-derived suppressive cells enhance cancer immunotherapy-focus serum-derived exosomes isolated therapy-induced pim1 activation immune cell populations checkpoint molecules spd-l1 tcr-independent stimulator targeting pim1-mediated metabolism cell infusion products anti-tumor cytotoxic killing human leukocyte antigens t-cell suppression mantle cell lymphoma single cells color-coded showed transcriptomic reprogramming 2d-density plots showing
Schema {🗺️}
WebPage:
mainEntity:
headline:TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
description:Chimeric antigen receptor (CAR) T-cell therapy using brexucabtagene autoleucel (BA) induces remission in many patients with mantle cell lymphoma (MCL), and BA is the only CAR T-cell therapy approved by the FDA for MCL. However, development of relapses to BA is recognized with poor patient outcomes. Multiple CAR T-cell therapies have been approved for other lymphomas and the resistance mechanisms have been investigated. However, the mechanisms underlying BA relapse in MCL have not been investigated and whether any previously reported resistance mechanisms apply to BA-relapsed patients with MCL is unknown. To interrogate BA resistance mechanisms in MCL, we performed single-cell RNA sequencing on 39 longitudinally collected samples from 15 BA-treated patients, and multiplex cytokine profiling on 80 serial samples from 20 patients. We demonstrate that after BA relapse, the proportion of T cells, especially cytotoxic T cells (CTLs), decreased among non-tumor cells, while the proportion of myeloid cells correspondingly increased. TIGIT, LAG3, and CD96 were the predominant checkpoint molecules expressed on exhausted T cells and CTLs; only TIGIT was significantly increased after relapse. CTLs expanded during remission, and then contracted during relapse with upregulated TIGIT expression. Tumor cells also acquired TIGIT expression after relapse, leading to the enhanced interaction of tumor cell TIGIT with monocyte CD155/PVR. In myeloid cells, post-relapse HLA-II expression was reduced relative to pretreatment and during remission. Myeloid-derived suppressor cells (MDSCs) were enriched after relapse with elevated expression of activation markers, including CLU (clusterin) and VCAN (versican). Extracellular chemokines (CCL4, CXCL9, CXCL13), soluble checkpoint inhibitors (sPD-L1, sTIM3, s4-1BB), and soluble receptors (sIL-2R, sTNFRII) were decreased during remission but elevated after relapse. Our data demonstrate that multiple tumor-intrinsic and -extrinsic factors are associated with T-cell suppression and BA relapse. Among these, TIGIT appears to be the central player given its elevated expression after BA relapse in not only CTLs but also MCL cells. The acquisition of TIGIT expression on tumor cells is MCL-specific and has not been reported in other CAR T-treated diseases. Together, our data suggest that co-targeting TIGIT may prevent CAR T relapses and thus promote long-term progression-free survival in MCL patients.
datePublished:2022-09-26T00:00:00Z
dateModified:2022-09-26T00:00:00Z
pageStart:1
pageEnd:16
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12943-022-01655-0
keywords:
Mantle cell lymphoma
CAR T-cell therapy
Relapse
T cell suppression
Myeloid-derived suppressor cells
Immune checkpoint
TIGIT
Cytokines
Chemokines
Soluble receptors
Cancer Research
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig6_HTML.png
isPartOf:
name:Molecular Cancer
issn:
1476-4598
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Vivian Changying Jiang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Dapeng Hao
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Preetesh Jain
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yijing Li
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Qingsong Cai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yixin Yao
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Lei Nie
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yang Liu
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Jingling Jin
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Wei Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Heng-Huan Lee
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yuxuan Che
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Enyu Dai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Guangchun Han
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Ruiping Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Kunal Rai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Andrew Futreal
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Christopher Flowers
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Linghua Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
address:
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Michael Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
description:Chimeric antigen receptor (CAR) T-cell therapy using brexucabtagene autoleucel (BA) induces remission in many patients with mantle cell lymphoma (MCL), and BA is the only CAR T-cell therapy approved by the FDA for MCL. However, development of relapses to BA is recognized with poor patient outcomes. Multiple CAR T-cell therapies have been approved for other lymphomas and the resistance mechanisms have been investigated. However, the mechanisms underlying BA relapse in MCL have not been investigated and whether any previously reported resistance mechanisms apply to BA-relapsed patients with MCL is unknown. To interrogate BA resistance mechanisms in MCL, we performed single-cell RNA sequencing on 39 longitudinally collected samples from 15 BA-treated patients, and multiplex cytokine profiling on 80 serial samples from 20 patients. We demonstrate that after BA relapse, the proportion of T cells, especially cytotoxic T cells (CTLs), decreased among non-tumor cells, while the proportion of myeloid cells correspondingly increased. TIGIT, LAG3, and CD96 were the predominant checkpoint molecules expressed on exhausted T cells and CTLs; only TIGIT was significantly increased after relapse. CTLs expanded during remission, and then contracted during relapse with upregulated TIGIT expression. Tumor cells also acquired TIGIT expression after relapse, leading to the enhanced interaction of tumor cell TIGIT with monocyte CD155/PVR. In myeloid cells, post-relapse HLA-II expression was reduced relative to pretreatment and during remission. Myeloid-derived suppressor cells (MDSCs) were enriched after relapse with elevated expression of activation markers, including CLU (clusterin) and VCAN (versican). Extracellular chemokines (CCL4, CXCL9, CXCL13), soluble checkpoint inhibitors (sPD-L1, sTIM3, s4-1BB), and soluble receptors (sIL-2R, sTNFRII) were decreased during remission but elevated after relapse. Our data demonstrate that multiple tumor-intrinsic and -extrinsic factors are associated with T-cell suppression and BA relapse. Among these, TIGIT appears to be the central player given its elevated expression after BA relapse in not only CTLs but also MCL cells. The acquisition of TIGIT expression on tumor cells is MCL-specific and has not been reported in other CAR T-treated diseases. Together, our data suggest that co-targeting TIGIT may prevent CAR T relapses and thus promote long-term progression-free survival in MCL patients.
datePublished:2022-09-26T00:00:00Z
dateModified:2022-09-26T00:00:00Z
pageStart:1
pageEnd:16
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12943-022-01655-0
keywords:
Mantle cell lymphoma
CAR T-cell therapy
Relapse
T cell suppression
Myeloid-derived suppressor cells
Immune checkpoint
TIGIT
Cytokines
Chemokines
Soluble receptors
Cancer Research
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_Fig6_HTML.png
isPartOf:
name:Molecular Cancer
issn:
1476-4598
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Vivian Changying Jiang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Dapeng Hao
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Preetesh Jain
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yijing Li
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Qingsong Cai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yixin Yao
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Lei Nie
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yang Liu
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Jingling Jin
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Wei Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Heng-Huan Lee
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Yuxuan Che
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Enyu Dai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Guangchun Han
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Ruiping Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Kunal Rai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Andrew Futreal
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Christopher Flowers
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:Linghua Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
address:
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Michael Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Molecular Cancer
issn:
1476-4598
volumeNumber:21
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
address:
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Vivian Changying Jiang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Dapeng Hao
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Preetesh Jain
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Yijing Li
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Qingsong Cai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Yixin Yao
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Lei Nie
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Yang Liu
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Jingling Jin
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Wei Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Heng-Huan Lee
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Yuxuan Che
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Enyu Dai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Guangchun Han
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Ruiping Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Kunal Rai
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Andrew Futreal
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Christopher Flowers
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:Linghua Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS)
address:
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
name:Michael Wang
affiliation:
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:the University of Texas MD Anderson Cancer Center
address:
name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, USA
name:The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, USA
name:Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, USA
name:Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas MD Anderson Cancer Center, Houston, USA
External Links {🔗}(231)
- What is the earnings of https://www.springernature.com/gp/authors?
- https://link.springernature.com/home/'s financial summary
- See how much https://order.springer.com/public/cart makes per month
- Get to know https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's earnings
- How much does https://molecular-cancer.biomedcentral.com/about pull in monthly?
- Find out how much https://submission.nature.com/new-submission/12943/3 earns monthly
- How much cash flow does https://doi.org/10.1056%2FNEJMoa1914347 have monthly?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32242358 makes per month
- Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731441
- Get to know http://scholar.google.com/scholar_lookup?&title=KTE-X19%20CAR%20T-cell%20therapy%20in%20relapsed%20or%20refractory%20mantle-cell%20lymphoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1914347&volume=382&pages=1331-1342&publication_year=2020&author=Wang%2CM&author=Munoz%2CJ&author=Goy%2CA&author=Locke%2CFL&author=Jacobson%2CCA&author=Hill%2CBT&author=Timmerman%2CJM&author=Holmes%2CH&author=Jaglowski%2CS&author=Flinn%2CIW's earnings
- Get to know https://doi.org/10.1111%2Fbjh.17197's earnings
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33152104
- How much money does http://scholar.google.com/scholar_lookup?&title=Outcomes%20and%20management%20of%20patients%20with%20mantle%20cell%20lymphoma%20after%20progression%20on%20brexucabtagene%20autoleucel%20therapy&journal=Br%20J%20Haematol&doi=10.1111%2Fbjh.17197&volume=192&pages=e38-e42&publication_year=2021&author=Jain%2CP&author=Nastoupil%2CL&author=Westin%2CJ&author=Lee%2CHJ&author=Navsaria%2CL&author=Steiner%2CRE&author=Ahmed%2CS&author=Moghrabi%2CO&author=Oriabure%2CO&author=Chen%2CW make?
- Revenue of https://doi.org/10.1056%2FNEJMoa1707447
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29226797 produce monthly?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882485
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Axicabtagene%20ciloleucel%20CAR%20T-cell%20therapy%20in%20refractory%20large%20B-cell%20cymphoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1707447&volume=377&pages=2531-2544&publication_year=2017&author=Neelapu%2CSS&author=Locke%2CFL&author=Bartlett%2CNL&author=Lekakis%2CLJ&author=Miklos%2CDB&author=Jacobson%2CCA&author=Braunschweig%2CI&author=Oluwole%2COO&author=Siddiqi%2CT&author=Lin%2CY
- Financial intake of https://doi.org/10.1056%2FNEJMoa1804980
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30501490?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Tisagenlecleucel%20in%20adult%20relapsed%20or%20refractory%20diffuse%20large%20B-cell%20lymphoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1804980&volume=380&pages=45-56&publication_year=2019&author=Schuster%2CSJ&author=Bishop%2CMR&author=Tam%2CCS&author=Waller%2CEK&author=Borchmann%2CP&author=McGuirk%2CJP&author=Jager%2CU&author=Jaglowski%2CS&author=Andreadis%2CC&author=Westin%2CJR is on a monthly basis
- Learn how profitable https://doi.org/10.1182%2Fblood.2020007445 is on a monthly basis
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33512407?
- What's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120145?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Tumor%20interferon%20signaling%20and%20suppressive%20myeloid%20cells%20are%20associated%20with%20CAR%20T-cell%20failure%20in%20large%20B-cell%20lymphoma&journal=Blood&doi=10.1182%2Fblood.2020007445&volume=137&pages=2621-2633&publication_year=2021&author=Jain%2CMD&author=Zhao%2CH&author=Wang%2CX&author=Atkins%2CR&author=Menges%2CM&author=Reid%2CK&author=Spitler%2CK&author=Faramand%2CR&author=Bachmeier%2CC&author=Dean%2CEA?
- Monthly income for https://doi.org/10.1158%2F2159-8290.CD-19-0813
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32001516's financial summary
- What's the profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416790?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Impaired%20death%20receptor%20signaling%20in%20leukemia%20causes%20antigen-independent%20resistance%20by%20inducing%20CAR%20T-cell%20dysfunction&journal=Cancer%20Discov&doi=10.1158%2F2159-8290.CD-19-0813&volume=10&pages=552-567&publication_year=2020&author=Singh%2CN&author=Lee%2CYG&author=Shestova%2CO&author=Ravikumar%2CP&author=Hayer%2CKE&author=Hong%2CSJ&author=Lu%2CXM&author=Pajarillo%2CR&author=Agarwal%2CS&author=Kuramitsu%2CS?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30837712 earns monthly
- How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214555 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20resistance%20to%20CAR%20T%20cell%20therapy&journal=Nat%20Rev%20Clin%20Oncol&volume=16&pages=372-385&publication_year=2019&author=Shah%2CNN&author=Fry%2CTJ pull in?
- Revenue of https://doi.org/10.1016%2Fj.coi.2021.02.010
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33752101?
- How much does http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20response%20and%20resistance%20to%20CAR%20T%20cell%20therapies&journal=Curr%20Opin%20Immunol&doi=10.1016%2Fj.coi.2021.02.010&volume=69&pages=56-64&publication_year=2021&author=Berger%2CTR&author=Maus%2CMV rake in every month?
- What's the financial intake of https://doi.org/10.1158%2F2159-8290.CD-19-0945?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32193224 make?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939454 net monthly?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Tuning%20the%20antigen%20density%20requirement%20for%20CAR%20T-cell%20activity&journal=Cancer%20Discov&doi=10.1158%2F2159-8290.CD-19-0945&volume=10&pages=702-723&publication_year=2020&author=Majzner%2CRG&author=Rietberg%2CSP&author=Sotillo%2CE&author=Dong%2CR&author=Vachharajani%2CVT&author=Labanieh%2CL&author=Myklebust%2CJH&author=Kadapakkam%2CM&author=Weber%2CEW&author=Tousley%2CAM making per month?
- Learn about the earnings of https://doi.org/10.3389%2Ffimmu.2019.02664
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31798590 generate?
- Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863137
- How much money does http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20relapse%20after%20CD19%20CAR%20T-cell%20therapy%20for%20acute%20lymphoblastic%20leukemia%20and%20its%20prevention%20and%20treatment%20strategies&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2019.02664&volume=10&publication_year=2019&author=Xu%2CX&author=Sun%2CQ&author=Liang%2CX&author=Chen%2CZ&author=Zhang%2CX&author=Zhou%2CX&author=Li%2CM&author=Tu%2CH&author=Liu%2CY&author=Tu%2CS&author=Li%2CY generate?
- How much profit does https://doi.org/10.1126%2Fsciimmunol.abd4344 make?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33771887
- How much money does http://scholar.google.com/scholar_lookup?&title=A%20cross-talk%20between%20CAR%20T%20cell%20subsets%20and%20the%20tumor%20microenvironment%20is%20essential%20for%20sustained%20cytotoxic%20activity&journal=Sci%20Immunol&doi=10.1126%2Fsciimmunol.abd4344&volume=6&publication_year=2021&author=Boulch%2CM&author=Cazaux%2CM&author=Loe-Mie%2CY&author=Thibaut%2CR&author=Corre%2CB&author=Lemaitre%2CF&author=Grandjean%2CCL&author=Garcia%2CZ&author=Bousso%2CP make?
- How much does https://doi.org/10.1038%2Fs41591-020-1061-7 gross monthly?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33020644?
- How much profit is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446909 making per month?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Characteristics%20of%20anti-CD19%20CAR%20T%20cell%20infusion%20products%20associated%20with%20efficacy%20and%20toxicity%20in%20patients%20with%20large%20B%20cell%20lymphomas&journal=Nat%20Med&doi=10.1038%2Fs41591-020-1061-7&volume=26&pages=1878-1887&publication_year=2020&author=Deng%2CQ&author=Han%2CG&author=Puebla-Osorio%2CN&author=Ma%2CMCJ&author=Strati%2CP&author=Chasen%2CB&author=Dai%2CE&author=Dang%2CM&author=Jain%2CN&author=Yang%2CH
- How much does https://doi.org/10.1158%2F2159-8290.CD-20-1677 bring in each month?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33820778
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419030 rake in every month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Integrative%20bulk%20and%20single-cell%20profiling%20of%20premanufacture%20T-cell%20populations%20reveals%20factors%20mediating%20long-term%20persistence%20of%20CAR%20T-cell%20therapy&journal=Cancer%20Discov&doi=10.1158%2F2159-8290.CD-20-1677&volume=11&pages=2186-2199&publication_year=2021&author=Chen%2CGM&author=Chen%2CC&author=Das%2CRK&author=Gao%2CP&author=Chen%2CCH&author=Bandyopadhyay%2CS&author=Ding%2CYY&author=Uzun%2CY&author=Yu%2CW&author=Zhu%2CQ produce monthly?
- Learn about the earnings of https://doi.org/10.1158%2F2159-8290.CD-20-1661
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33837065 make?
- What's the revenue for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561746?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=IFNgamma%20is%20critical%20for%20CAR%20T%20cell-mediated%20cyeloid%20activation%20and%20induction%20of%20endogenous%20immunity&journal=Cancer%20Discov&doi=10.1158%2F2159-8290.CD-20-1661&volume=11&pages=2248-2265&publication_year=2021&author=Alizadeh%2CD&author=Wong%2CRA&author=Gholamin%2CS&author=Maker%2CM&author=Aftabizadeh%2CM&author=Yang%2CX&author=Pecoraro%2CJR&author=Jeppson%2CJD&author=Wang%2CD&author=Aguilar%2CB
- What's the total monthly financial gain of https://doi.org/10.1038%2Fs41467-021-22872-z?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34001881?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128874 make?
- See how much http://scholar.google.com/scholar_lookup?&title=Longitudinal%20single-cell%20profiling%20reveals%20molecular%20heterogeneity%20and%20tumor-immune%20evolution%20in%20refractory%20mantle%20cell%20lymphoma&journal=Nat%20Commun&doi=10.1038%2Fs41467-021-22872-z&volume=12&publication_year=2021&author=Zhang%2CS&author=Jiang%2CVC&author=Han%2CG&author=Hao%2CD&author=Lian%2CJ&author=Liu%2CY&author=Zhang%2CR&author=McIntosh%2CJ&author=Wang%2CR&author=Dang%2CM makes per month
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=iTALK%3A%20an%20R%20package%20to%20characterize%20and%20illustrate%20intercellular%20communication&journal=BioRxiv&volume=1&publication_year=2019&author=Yuanxin%20Wang%2CRW&author=Zhang%2CS&author=Song%2CS&author=Jiang%2CC&author=Han%2CG&author=Wang%2CM&author=Ajani%2CJ&author=Futreal%2CA&author=Wang%2CL?
- How much cash flow does https://doi.org/10.1038%2Fs41598-020-70584-z have monthly?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32826923
- Monthly income for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442638
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Cytokine%20profiling%20in%20serum-derived%20exosomes%20isolated%20by%20different%20methods&journal=Sci%20Rep&doi=10.1038%2Fs41598-020-70584-z&volume=10&publication_year=2020&author=Jung%2CHH&author=Kim%2CJY&author=Lim%2CJE&author=Im%2CYH
- How much money does https://doi.org/10.1136%2Fjitc-2021-002899 make?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34353849 bring in?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344275?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Deregulation%20of%20HLA-I%20in%20cancer%20and%20its%20central%20importance%20for%20immunotherapy&journal=J%20Immunother%20Cancer&doi=10.1136%2Fjitc-2021-002899&volume=9&publication_year=2021&author=Hazini%2CA&author=Fisher%2CK&author=Seymour%2CL
- How much revenue does https://doi.org/10.3892%2Fol.2017.6784 generate?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29085437's total income per month
- What's the revenue for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649701?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=HLA-mediated%20tumor%20escape%20mechanisms%20that%20may%20impair%20immunotherapy%20clinical%20outcomes%20via%20T-cell%20activation&journal=Oncol%20Lett&doi=10.3892%2Fol.2017.6784&volume=14&pages=4415-4427&publication_year=2017&author=Rodriguez%2CJA
- Revenue of https://doi.org/10.1038%2Fs41577-020-00490-y
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33526920 generate?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849958?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Myeloid-derived%20suppressor%20cells%20in%20the%20era%20of%20increasing%20myeloid%20cell%20diversity&journal=Nat%20Rev%20Immunol&doi=10.1038%2Fs41577-020-00490-y&volume=21&pages=485-498&publication_year=2021&author=Veglia%2CF&author=Sanseviero%2CE&author=Gabrilovich%2CDI
- What's the monthly income of https://doi.org/10.1126%2Fscitranslmed.aav5599?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31217338 generate monthly?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724184?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Targetable%20genetic%20alterations%20of%20TCF4%20%28E2-2%29%20drive%20immunoglobulin%20expression%20in%20diffuse%20large%20B%20cell%20lymphoma&journal=Sci%20Transl%20Med&doi=10.1126%2Fscitranslmed.aav5599&volume=11&publication_year=2019&author=Jain%2CN&author=Hartert%2CK&author=Tadros%2CS&author=Fiskus%2CW&author=Havranek%2CO&author=Ma%2CMCJ&author=Bouska%2CA&author=Heavican%2CT&author=Kumar%2CD&author=Deng%2CQ?
- What's the total monthly financial gain of https://doi.org/10.1182%2Fblood.2019003880?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32315407 bring in each month?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Targeting%20cytokine-%20and%20therapy-induced%20PIM1%20activation%20in%20preclinical%20models%20of%20T-cell%20acute%20lymphoblastic%20leukemia%20and%20lymphoma&journal=Blood&doi=10.1182%2Fblood.2019003880&volume=135&pages=1685-1695&publication_year=2020&author=Smedt%2CR&author=Morscio%2CJ&author=Reunes%2CL&author=Roels%2CJ&author=Bardelli%2CV&author=Lintermans%2CB&author=Loocke%2CW&author=Almeida%2CA&author=Cheung%2CLC&author=Kotecha%2CRS make?
- What's the revenue for https://doi.org/10.3389%2Ffimmu.2019.00481?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30930905 gross monthly?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423481 gross monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Targeting%20the%20antibody%20checkpoints%20to%20enhance%20cancer%20immunotherapy-focus%20on%20fcgammaRIIB&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2019.00481&volume=10&publication_year=2019&author=Teige%2CI&author=Martensson%2CL&author=Frendeus%2CBL make?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32060843?
- How much does http://scholar.google.com/scholar_lookup?&title=CCL4%20signaling%20in%20the%20tumor%20microenvironment&journal=Adv%20Exp%20Med%20Biol&doi=10.1007%2F978-3-030-36667-4_3&volume=1231&pages=23-32&publication_year=2020&author=Mukaida%2CN&author=Sasaki%2CSI&author=Baba%2CT make?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32060845?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=The%20multifaceted%20roles%20of%20CXCL9%20within%20the%20tumor%20microenvironment&journal=Adv%20Exp%20Med%20Biol&doi=10.1007%2F978-3-030-36667-4_5&volume=1231&pages=45-51&publication_year=2020&author=Neo%2CSY&author=Lundqvist%2CA bring in?
- Get to know what's the income of https://doi.org/10.1038%2Fs41467-019-10369-9
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31186412 generate?
- What's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559950?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=LIF%20regulates%20CXCL9%20in%20tumor-associated%20macrophages%20and%20prevents%20CD8%28%2B%29%20T%20cell%20tumor-infiltration%20impairing%20anti-PD1%20therapy&journal=Nat%20Commun&doi=10.1038%2Fs41467-019-10369-9&volume=10&publication_year=2019&author=Pascual-Garcia%2CM&author=Bonfill-Teixidor%2CE&author=Planas-Rigol%2CE&author=Rubio-Perez%2CC&author=Iurlaro%2CR&author=Arias%2CA&author=Cuartas%2CI&author=Sala-Hojman%2CA&author=Escudero%2CL&author=Martinez-Ricarte%2CF?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34286442
- How much income does http://scholar.google.com/scholar_lookup?&title=CXCL13%20signaling%20in%20the%20tumor%20microenvironment&journal=Adv%20Exp%20Med%20Biol&doi=10.1007%2F978-3-030-62658-7_6&volume=1302&pages=71-90&publication_year=2021&author=Hussain%2CM&author=Liu%2CJ&author=Wang%2CGZ&author=Zhou%2CGB have?
- What's the financial outcome of https://doi.org/10.1038%2Fs41598-019-46491-3?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31628349?
- Earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802083
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Transcriptome%20network%20analysis%20identifies%20CXCL13-CXCR5%20signaling%20modules%20in%20the%20prostate%20tumor%20immune%20microenvironment&journal=Sci%20Rep&doi=10.1038%2Fs41598-019-46491-3&volume=9&publication_year=2019&author=Ohandjo%2CAQ&author=Liu%2CZ&author=Dammer%2CEB&author=Dill%2CCD&author=Griffen%2CTL&author=Carey%2CKM&author=Hinton%2CDE&author=Meller%2CR&author=Lillard%2CJW?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31783776
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884764?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Soluble%20immune%20checkpoint-related%20proteins%20as%20predictors%20of%20tumor%20recurrence%2C%20survival%2C%20and%20T%20cell%20phenotypes%20in%20clear%20cell%20renal%20cell%20carcinoma%20patients&journal=J%20Immunother%20Cancer&doi=10.1186%2Fs40425-019-0810-y&volume=7&publication_year=2019&author=Wang%2CQ&author=Zhang%2CJ&author=Tu%2CH&author=Liang%2CD&author=Chang%2CDW&author=Ye%2CY&author=Wu%2CX?
- What's https://doi.org/10.2147%2FCMAR.S162478's gross income?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29760564?
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937498 produce monthly?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Highly%20elevated%20soluble%20Tim-3%20levels%20correlate%20with%20increased%20hepatocellular%20carcinoma%20risk%20and%20poor%20survival%20of%20hepatocellular%20carcinoma%20patients%20in%20chronic%20hepatitis%20B%20virus%20infection&journal=Cancer%20Manag%20Res&doi=10.2147%2FCMAR.S162478&volume=10&pages=941-951&publication_year=2018&author=Li%2CF&author=Li%2CN&author=Sang%2CJ&author=Fan%2CX&author=Deng%2CH&author=Zhang%2CX&author=Han%2CQ&author=Lv%2CY&author=Liu%2CZ make?
- How much does https://doi.org/10.3389%2Ffonc.2019.01015 pull in?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31681568
- What's the revenue for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803523?
- How much does http://scholar.google.com/scholar_lookup?&title=Soluble%20programmed%20death%20receptor%20ligands%20sPD-L1%20and%20sPD-L2%20as%20liquid%20biopsy%20markers%20for%20prognosis%20and%20platinum%20response%20in%20epithelial%20ovarian%20cancer&journal=Front%20Oncol&doi=10.3389%2Ffonc.2019.01015&volume=9&publication_year=2019&author=Buderath%2CP&author=Schwich%2CE&author=Jensen%2CC&author=Horn%2CPA&author=Kimmig%2CR&author=Kasimir-Bauer%2CS&author=Rebmann%2CV bring in each month?
- Earnings of https://doi.org/10.1111%2Fbjh.17502
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34019713 is on a monthly basis
- Find out how much http://scholar.google.com/scholar_lookup?&title=Screening%20and%20monitoring%20of%20the%20BTK%28C481S%29%20mutation%20in%20a%20real-world%20cohort%20of%20patients%20with%20relapsed%2Frefractory%20chronic%20lymphocytic%20leukaemia%20during%20ibrutinib%20therapy&journal=Br%20J%20Haematol&doi=10.1111%2Fbjh.17502&volume=194&pages=355-364&publication_year=2021&author=Bodor%2CC&author=Kotmayer%2CL&author=Laszlo%2CT&author=Takacs%2CF&author=Barna%2CG&author=Kiss%2CR&author=Sebestyen%2CE&author=Nagy%2CT&author=Hegyi%2CLL&author=Mikala%2CG earns monthly
- Financial intake of https://doi.org/10.1126%2Fscitranslmed.aau1167
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31068440 pull in?
- How much money does http://scholar.google.com/scholar_lookup?&title=Metabolic%20reprogramming%20toward%20oxidative%20phosphorylation%20identifies%20a%20therapeutic%20target%20for%20mantle%20cell%20lymphoma&journal=Sci%20Transl%20Med&doi=10.1126%2Fscitranslmed.aau1167&volume=11&publication_year=2019&author=Zhang%2CL&author=Yao%2CY&author=Zhang%2CS&author=Liu%2CY&author=Guo%2CH&author=Ahmed%2CM&author=Bell%2CT&author=Zhang%2CH&author=Han%2CG&author=Lorence%2CE generate?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29851933's total income per month
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469642?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20use%20of%20chimeric%20antigen%20receptor%20T%20cells%20in%20patients%20with%20non-Hodgkin%20lymphoma&journal=Clin%20Adv%20Hematol%20Oncol&volume=16&pages=375-386&publication_year=2018&author=Lulla%2CPD&author=Hill%2CLC&author=Ramos%2CCA&author=Heslop%2CHE rake in every month?
- How much does https://doi.org/10.1158%2F2159-8290.CD-21-1586 make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35554512 pull in?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Sequential%20single-cell%20transcriptional%20and%20protein%20marker%20profiling%20reveals%20TIGIT%20as%20a%20marker%20of%20CD19%20CAR-T%20cell%20dysfunction%20in%20patients%20with%20non-Hodgkin%20lymphoma&journal=Cancer%20Discovery&doi=10.1158%2F2159-8290.CD-21-1586&volume=12&pages=1886-1903&publication_year=2022&author=Jackson%2CZ&author=Hong%2CCJ&author=Schauner%2CR&author=Dropulic%2CB&author=Caimi%2CPF&author=Lima%2CM&author=Giraudo%2CMF&author=Gupta%2CK&author=Reese%2CJS&author=Hwang%2CTH&author=Wald%2CDN generate?
- How much does https://doi.org/10.3389%2Ffimmu.2018.02821 make?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30555485 is on a monthly basis
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281988 net monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Intrinsic%20expression%20of%20immune%20checkpoint%20molecule%20TIGIT%20could%20help%20tumor%20growth%20in%20vivo%20by%20suppressing%20the%20function%20of%20NK%20and%20CD8%28%2B%29%20t%20cells&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2018.02821&volume=9&publication_year=2018&author=Zhou%2CXM&author=Li%2CWQ&author=Wu%2CYH&author=Han%2CL&author=Cao%2CXG&author=Yang%2CXM&author=Wang%2CHF&author=Zhao%2CWS&author=Zhai%2CWJ&author=Qi%2CYM&author=Gao%2CYF net monthly?
- What's the income of https://doi.org/10.3389%2Ffonc.2020.00188?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32161718 pull in?
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052362 make?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Tumor-associated%20macrophages%3A%20recent%20insights%20and%20therapies&journal=Front%20Oncol&doi=10.3389%2Ffonc.2020.00188&volume=10&publication_year=2020&author=Zhou%2CJ&author=Tang%2CZ&author=Gao%2CS&author=Li%2CC&author=Feng%2CY&author=Zhou%2CX?
- How much does https://doi.org/10.3390%2Fjcm10132872 make?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34203451 making per month?
- Financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268873
- What's http://scholar.google.com/scholar_lookup?&title=MDSC%20in%20mice%20and%20men%3A%20mechanisms%20of%20immunosuppression%20in%20cancer&journal=J%20Clin%20Med&doi=10.3390%2Fjcm10132872&volume=10&publication_year=2021&author=Vanhaver%2CC&author=Bruggen%2CP&author=Bruger%2CAM's gross income?
- How much profit is https://doi.org/10.1016%2Fj.cellimm.2021.104302 making per month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33592540 gross monthly?
- Earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054443
- How much money does http://scholar.google.com/scholar_lookup?&title=Myeloid-derived%20suppressor%20cells%20%28MDSC%29%3A%20when%20good%20intentions%20go%20awry&journal=Cell%20Immunol&doi=10.1016%2Fj.cellimm.2021.104302&volume=362&publication_year=2021&author=Sanchez-Pino%2CMD&author=Dean%2CMJ&author=Ochoa%2CAC generate?
- Revenue of https://doi.org/10.1016%2Fj.immuni.2021.04.004
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33979585 rake in every month?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709560?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=MDSC%3A%20markers%2C%20development%2C%20states%2C%20and%20unaddressed%20complexity&journal=Immunity&doi=10.1016%2Fj.immuni.2021.04.004&volume=54&pages=875-884&publication_year=2021&author=Hegde%2CS&author=Leader%2CAM&author=Merad%2CM?
- Discover the revenue of https://doi.org/10.1038%2Fsrep29521
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27405665
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942787 make?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Therapeutic%20targeting%20of%20myeloid-derived%20suppressor%20cells%20involves%20a%20novel%20mechanism%20mediated%20by%20clusterin&journal=Sci%20Rep&doi=10.1038%2Fsrep29521&volume=6&publication_year=2016&author=Zhou%2CJM&author=Donatelli%2CSS&author=Gilvary%2CDL&author=Tejera%2CMM&author=Eksioglu%2CEA&author=Chen%2CXH&author=Coppola%2CD&author=Wei%2CS&author=Djeu%2CJY?
- How much revenue does https://doi.org/10.1158%2F0008-5472.CAN-11-2905 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22282653 net monthly?
- Earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543151
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Myeloid%20progenitor%20cells%20in%20the%20Premetastatic%20lung%20promote%20metastases%20by%20inducing%20mesenchymal%20to%20epithelial%20transition&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-11-2905&volume=72&pages=1384-1394&publication_year=2012&author=Gao%2CDC&author=Joshi%2CN&author=Choi%2CHJ&author=Ryu%2CSH&author=Hahn%2CM&author=Catena%2CR&author=Sadik%2CH&author=Argani%2CP&author=Wagner%2CP&author=Vahdat%2CLT?
- Learn how profitable https://doi.org/10.3390%2Fcells9081785 is on a monthly basis
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464644 produce monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Role%20of%20tumor-associated%20myeloid%20cells%20in%20breast%20cancer&journal=Cells&doi=10.3390%2Fcells9081785&volume=9&publication_year=2020&author=Cha%2CYJ&author=Koo%2CJS bring in?
- Revenue of https://doi.org/10.1080%2F2162402X.2018.1469594
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30228937 produce monthly?
- How profitable is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140587?
- What's the income of http://scholar.google.com/scholar_lookup?&title=VISTA%20is%20highly%20expressed%20on%20MDSCs%20and%20mediates%20an%20inhibition%20of%20T%20cell%20response%20in%20patients%20with%20AML&journal=Oncoimmunology&doi=10.1080%2F2162402X.2018.1469594&volume=7&publication_year=2018&author=Wang%2CL&author=Jia%2CB&author=Claxton%2CDF&author=Ehmann%2CWC&author=Rybka%2CWB&author=Mineishi%2CS&author=Naik%2CS&author=Khawaja%2CMR&author=Sivik%2CJ&author=Han%2CJ?
- Get to know https://doi.org/10.1158%2F2326-6066.CIR-20-0433's earnings
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33579728?
- Get to know http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137571's earnings
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Targeting%20PIM1-mediated%20metabolism%20in%20myeloid%20suppressor%20cells%20to%20treat%20cancer&journal=Cancer%20Immunology%20Research&doi=10.1158%2F2326-6066.CIR-20-0433&volume=9&pages=454-469&publication_year=2021&author=Xin%2CG&author=Chen%2CY&author=Topchyan%2CP&author=Kasmani%2CMY&author=Burns%2CR&author=Volberding%2CPJ&author=Wu%2CXP&author=Cohn%2CA&author=Chen%2CYL&author=Lin%2CCW?
- How much revenue does https://doi.org/10.1158%2F0008-5472.CAN-16-0839 produce monthly?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27503932
- Discover the revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050142
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Adaptive%20NK%20cells%20with%20low%20TIGIT%20expression%20are%20inherently%20resistant%20to%20myeloid-derived%20suppressor%20cells&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-16-0839&volume=76&pages=5696-5706&publication_year=2016&author=Sarhan%2CD&author=Cichocki%2CF&author=Zhang%2CB&author=Yingst%2CA&author=Spellman%2CSR&author=Cooley%2CS&author=Verneris%2CMR&author=Blazar%2CBR&author=Miller%2CJS?
- Get to know what's the income of https://citation-needed.springer.com/v2/references/10.1186/s12943-022-01655-0?format=refman&flavour=references
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Vivian%20Changying%20Jiang
- What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Vivian%20Changying%20Jiang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dapeng%20Hao?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dapeng%20Hao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Preetesh%20Jain rake in every month?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Preetesh%20Jain%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yijing%20Li net monthly?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yijing%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Qingsong%20Cai's financial summary
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Qingsong%20Cai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yixin%20Yao?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yixin%20Yao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lei%20Nie produce monthly?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lei%20Nie%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yang%20Liu generate?
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yang%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jingling%20Jin generate monthly?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jingling%20Jin%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wei%20Wang?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wei%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Heng-Huan%20Lee generate monthly?
- Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Heng-Huan%20Lee%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuxuan%20Che gross monthly?
- What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuxuan%20Che%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Enyu%20Dai net monthly?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Enyu%20Dai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Guangchun%20Han bring in each month?
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Guangchun%20Han%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ruiping%20Wang's revenue stream
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ruiping%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kunal%20Rai
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kunal%20Rai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Andrew%20Futreal generate?
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Andrew%20Futreal%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christopher%20Flowers make?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christopher%20Flowers%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Linghua%20Wang?
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Linghua%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michael%20Wang net monthly?
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michael%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Income figures for https://static-content.springer.com/esm/art%3A10.1186%2Fs12943-022-01655-0/MediaObjects/12943_2022_1655_MOESM1_ESM.docx
- How much does http://creativecommons.org/licenses/by/4.0/ make?
- What's the profit of http://creativecommons.org/publicdomain/zero/1.0/?
- What's the profit of https://s100.copyright.com/AppDispatchServlet?title=TIGIT%20is%20the%20central%20player%20in%20T-cell%20suppression%20associated%20with%20CAR%20T-cell%20relapse%20in%20mantle%20cell%20lymphoma&author=Vivian%20Changying%20Jiang%20et%20al&contentID=10.1186%2Fs12943-022-01655-0©right=The%20Author%28s%29&publication=1476-4598&publicationDate=2022-09-26&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0?
- How much does https://crossmark.crossref.org/dialog/?doi=10.1186/s12943-022-01655-0 generate monthly?
- https://citation-needed.springer.com/v2/references/10.1186/s12943-022-01655-0?format=refman&flavour=citation income
- How much revenue does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral bring in?
- How much does https://www.springernature.com/gp/products earn?
- What's the financial gain of https://www.springernature.com/gp/librarians?
- What's https://www.springernature.com/gp/societies's gross income?
- Find out how much https://www.springernature.com/gp/partners earns monthly
- What's the income generated by https://www.springer.com/ each month?
- How profitable is https://www.nature.com/?
- What's the revenue for https://www.biomedcentral.com/?
- How profitable is https://www.palgrave.com/?
- Explore the financials of https://www.apress.com/
- How profitable is https://www.springernature.com/gp/legal/ccpa?
- How much does https://www.springernature.com/gp/info/accessibility rake in every month?
- How profitable is https://support.springernature.com/en/support/home?
- https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations's financial summary
- What's the financial gain of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref